Stock screener

NAUT

Conviction 47IndustrialsScan · Thu, Jun 25, 2026
NAUT$2.27-3.81%
ResistanceSupportVol 14Insider sell
63 bars
12
Vol MA14 454.8K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Nautilus Biotechnology, Inc.LABORATORY ANALYTICAL INSTRUMENTSwww.nautilus.bio
Price2.27
Change-3.81%
Gap-1.69%
Rel volume2.89×
Avg volume450.28K
Avg $ vol1.08M
SMA 202.40
SMA 502.59
SMA 2002.12
Price vs 50-12.51%
Price vs 200+6.89%
MA stackmixed
50/200 cross
Supertrenddown · 2.69
RSI (14)42
MACD hist0.01
MACD crossbull · 2d
Stoch %K / %D29 / 34
ADX (14)19
+DI / −DI14 / 24
RSI divergence
MACD divergenceBullish
ATR %+7.16%
ADR %6.37%
52w high3.95
52w low0.6390
From 52w high-42.53%
Above 52w low+255.24%
New 52w highNo
SqueezeOff
Bollinger width31.52%
%B0.32
Donchian pos20.50%
Donchian high2.89
Donchian low2.11
AVWAP (52w high)2.77
vs AVWAP high-18.19%
AVWAP (52w low)2.07
vs AVWAP low+9.78%
OBV trendFlat
Chaikin MF (20)-0.24
Today vs 20d2.89×
Avg vol (14d)454.8K
Avg vol (20d)450.28K
Avg $ vol (20d)1.08M
Market cap288.47M
RS 3m (vs SPY)-52.51%
RS 6m (vs SPY)+13.91%
RS line new highNo
Trend template4/8
Technical rank50.3
1 week+4.13%
1 month-6.58%
3 months-41.94%
6 months+14.65%
1 year+216.16%
YTD+18.85%
P/E-4.89
P/B2.00
P/S
P/FCF-5.55
EPS-0.4700
Div yield
ROE-40.86%
ROA-33.19%
Debt/Eq
Current11.85
EV/EBITDA
Gross margin
Net margin
Rev growth
EPS growth16.64%
Price target
Target upside
Analyst rating
Institutional
Ent. value273.84M
Revenue
Net income-14.7M
Gross profit
Free cash flow-51.97M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out127.08M
Employees130
ListedThu, Jun 10, 2021
Free float34.72M
Float %27.4%
Short interest760.16K
Days to cover1.8d
Short volume35.2%
Squeeze score28 / 100
Next earningsThu, Jul 30, 2026 (35d)
EPS forecast
Last EPS vs est
Last surprise
Setup gradeC
Conviction47 / 100
Pattern quality
Tech rank50.3 / 100
Group rank77 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance3.11
Support2.20
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NAUT

All disclosures →
No recent disclosed trades by Congress in NAUT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NAUT · 5 buys · 5 sells

InsiderSideShares
NAZEM FARZAD
Director · Stock Option (Right to Buy) · 2026-06-18
Grant45K
Posard Matthew L.
Director · Stock Option (Right to Buy) · 2026-06-18
Grant45K
Akinsanya Karen
Director · Stock Option (Right to Buy) · 2026-06-18
Grant45K
McIlwain Matthew S
Director · Stock Option (Right to Buy) · 2026-06-18
Grant45K
Epperly Melissa B,
Director · Stock Option (Right to Buy) · 2026-06-18
Grant45K
HOROWITZ BENJAMIN A
10% owner · Common Stock · 2026-06-02
Sell384.03K
AH Equity Partners Bio II, L.L.C.
10% owner · Common Stock · 2026-06-02
Sell384.03K
AH Equity Partners LSV II, L.L.C.
10% owner · Common Stock · 2026-06-02
Sell384.03K
AH Bio Fund II, L.P.
10% owner · Common Stock · 2026-06-02
Sell384.03K
Andreessen Horowitz LSV Fund II, L.P.
10% owner · Common Stock · 2026-06-02
Sell384.03K

SEC filings

EDGAR filings in NAUT · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.